{"id":7502,"date":"2026-02-28T13:53:52","date_gmt":"2026-02-28T13:53:52","guid":{"rendered":"https:\/\/dachtimes.com\/nicola-stephens-directrice-dincyte-suisse-la-suisse-romande-est-aussi-un-centre-de-gravite-pour-lindustrie-pharmaceutique\/"},"modified":"2026-02-28T13:53:52","modified_gmt":"2026-02-28T13:53:52","slug":"nicola-stephens-directrice-dincyte-suisse-la-suisse-romande-est-aussi-un-centre-de-gravite-pour-lindustrie-pharmaceutique","status":"publish","type":"post","link":"https:\/\/dachtimes.com\/fr\/nicola-stephens-directrice-dincyte-suisse-la-suisse-romande-est-aussi-un-centre-de-gravite-pour-lindustrie-pharmaceutique\/","title":{"rendered":"Nicola Stephens, directrice d\u2019Incyte Suisse: \u00abLa Suisse romande est aussi un centre de gravit\u00e9 pour l\u2019industrie pharmaceutique\u00bb"},"content":{"rendered":"<p><br \/>\n<\/p>\n<p>Pr\u00e9sente en Suisse depuis dix ans, l\u2019entreprise pharmaceutique am\u00e9ricaine Incyte a r\u00e9organis\u00e9 ses activit\u00e9s pour installer \u00e0 Morges (VD) son si\u00e8ge pour les affaires internationales (hors Etats-Unis) \u00e0 l\u2019automne 2024. Dans le cadre de cette transformation, elle a\u00a0\u00e9galement cr\u00e9\u00e9 une filiale d\u00e9di\u00e9e \u00e0 ses activit\u00e9s helv\u00e9tiques.<\/p>\n<p>D\u00e9but f\u00e9vrier, Incyte a obtenu l\u2019approbation de Swissmedic, l\u2019autorit\u00e9 de r\u00e9gulation du m\u00e9dicament, pour la commercialisation d\u2019Opzelura, un traitement pour le vitiligo non&#8230;<\/p>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.letemps.ch\/economie\/pharmas-medtech\/nicola-stephens-directrice-d-incyte-suisse-la-suisse-romande-est-aussi-un-centre-de-gravite-pour-l-industrie-pharmaceutique\" target=\"_blank\" rel=\"noopener\">Fonte <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pr\u00e9sente en Suisse depuis dix ans, l\u2019entreprise pharmaceutique am\u00e9ricaine Incyte a r\u00e9organis\u00e9 ses activit\u00e9s pour installer \u00e0 Morges (VD) son si\u00e8ge pour les affaires internationales (hors Etats-Unis) \u00e0 l\u2019automne 2024. Dans le cadre de cette transformation, elle a\u00a0\u00e9galement cr\u00e9\u00e9 une filiale d\u00e9di\u00e9e \u00e0 ses activit\u00e9s helv\u00e9tiques. D\u00e9but f\u00e9vrier, Incyte a obtenu l\u2019approbation de Swissmedic, l\u2019autorit\u00e9 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2027],"tags":[],"class_list":{"0":"post-7502","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-medtech"},"_links":{"self":[{"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/posts\/7502","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/comments?post=7502"}],"version-history":[{"count":0,"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/posts\/7502\/revisions"}],"wp:attachment":[{"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/media?parent=7502"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/categories?post=7502"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/tags?post=7502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}